Epicardial fat reduced in patients with type 2 diabetes and HF

The co-occurrence of heart failure (HF) and diabetes leads to a higher risk of complications, higher mortality and worse outcomes than either disease alone. Studies have shown the importance of epicardial adipose tissue (EAT) in the progression of cardiovascular disease. Its proximity to the myocardium, combined with its proinflammatory properties in disease, has sparked interest in the role of EAT in HF, particularly in patients with type 2 diabetes (T2D).